Health care resource utilization and costs in patients initiating natalizumab therapy for multiple sclerosis in the United States
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.491
https://www.valueinhealthjournal.com/article/S1098-3015(13)00562-7/fulltext
Section Title :
Neurological Disorders
Section Order :
33
First Page :
A104
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00562-7&doi=10.1016/j.jval.2013.03.491